Fundz

Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer

PRIVATENov 09, 2023

Position

Chief Executive Officer

Company

Century Therapeutics

Brent Pfeiffenberger
brent.pfeiffenberger@centurytx.com
PhiladelphiaManufacturingBiotechnologyHealthcareHealth CareTherapeutics

Description

Century Therapeutics, Inc. , an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology, today announced the appointment of Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer and member of the Board, effective December 4, 2023.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Century Therapeutics, and when

A new leader at Century Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Century Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Century Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Century Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Century Therapeutics

Location

1 BRIDGE PLAZA

Philadelphia, Pennsylvania, United States

About

Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell product candidates are designed to specifically target hematologic and solid tumor cancers. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Century Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Brent
Likely contact at this company
••••••••@••••••••

See Brent's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Century Therapeutics's next move

Learn about Strategic plan

Century Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.